Ben Atkins | Vice President-Communications and Investor Relations |
Roger Crystal | Chief Executive Officer |
David O’Toole | Chief Financial Officer |
Brandon Folkes | Cantor Fitzgerald |
Carl Byrnes | Northland Securities |
Brian Marckx | Zacks Investment Research |
Greetings and welcome to the Opiant Pharmaceuticals Fourth Quarter and Full Year 2019 Earnings Conference Call. [Operator Instructions] Please note, this conference is being recorded.
I will now turn the conference over to your host, Vice President of Communications and Investor Relations with Opiant Pharmaceuticals, Ben Atkins. Please go ahead sir.
Thank you, operator, and good afternoon, everyone.